2018-2023 Global Eukaryotic Expression Systems Market Report (Status and Outlook)

August 2018 | 119 pages | ID: 26054CC316FEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Eukaryotic Expression Systems market for 2018-2023.

Expression systems are used for the production of protein from recombinant DNA molecules (see Recombinant Proteins). They are of widespread use in industry, health care, and scientific research
Increasing cases of complex diseases such as cancer & other cardiovascular diseases and increasing research & development for therapeutics for such diseases are the main drivers of the growth of the market
Over the next five years, LPI(LP Information) projects that Eukaryotic Expression Systems will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares and growth opportunities of Eukaryotic Expression Systems market by product type, application, key companies and key regions.

To calculate the market size, LP Information considers value generated from the sales of the following segments:

Segmentation by product type:

• MEL
• COS
• Insect cells

Segmentation by application:

• Reagents
• Expression vectors
• Competent cells

We can also provide the customized separate regional or country-level reports, for the following regions:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

• Thermo Fisher
• Sigma Aldrich
• Jena Bioscience
• New England Biolabs
• Takara Bio
• Bio Rad
• Promega
• Agilent
• Merck Millipore

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Eukaryotic Expression Systems market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Eukaryotic Expression Systems market by identifying its various subsegments.
• Focuses on the key global Eukaryotic Expression Systems players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Eukaryotic Expression Systems with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the size of Eukaryotic Expression Systems submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Eukaryotic Expression Systems Market Size 2013-2023
  2.1.2 Eukaryotic Expression Systems Market Size CAGR by Region
2.2 Eukaryotic Expression Systems Segment by Type
  2.2.1 MEL
  2.2.2 COS
  2.2.3 CHO
  2.2.4 Insect cells
2.3 Eukaryotic Expression Systems Market Size by Type
  2.3.1 Global Eukaryotic Expression Systems Market Size Market Share by Type (2013-2018)
  2.3.2 Global Eukaryotic Expression Systems Market Size Growth Rate by Type (2013-2018)
2.4 Eukaryotic Expression Systems Segment by Application
  2.4.1 Reagents
  2.4.2 Expression vectors
  2.4.3 Competent cells
2.5 Eukaryotic Expression Systems Market Size by Application
  2.5.1 Global Eukaryotic Expression Systems Market Size Market Share by Application (2013-2018)
  2.5.2 Global Eukaryotic Expression Systems Market Size Growth Rate by Application (2013-2018)

3 GLOBAL EUKARYOTIC EXPRESSION SYSTEMS BY PLAYERS

3.1 Global Eukaryotic Expression Systems Market Size Market Share by Players
  3.1.1 Global Eukaryotic Expression Systems Market Size by Players (2016-2018)
  3.1.2 Global Eukaryotic Expression Systems Market Size Market Share by Players (2016-2018)
3.2 Global Eukaryotic Expression Systems Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 EUKARYOTIC EXPRESSION SYSTEMS BY REGIONS

4.1 Eukaryotic Expression Systems Market Size by Regions
4.2 Americas Eukaryotic Expression Systems Market Size Growth
4.3 APAC Eukaryotic Expression Systems Market Size Growth
4.4 Europe Eukaryotic Expression Systems Market Size Growth
4.5 Middle East & Africa Eukaryotic Expression Systems Market Size Growth

5 AMERICAS

5.1 Americas Eukaryotic Expression Systems Market Size by Countries
5.2 Americas Eukaryotic Expression Systems Market Size by Type
5.3 Americas Eukaryotic Expression Systems Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Eukaryotic Expression Systems Market Size by Countries
6.2 APAC Eukaryotic Expression Systems Market Size by Type
6.3 APAC Eukaryotic Expression Systems Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Eukaryotic Expression Systems by Countries
7.2 Europe Eukaryotic Expression Systems Market Size by Type
7.3 Europe Eukaryotic Expression Systems Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Eukaryotic Expression Systems by Countries
8.2 Middle East & Africa Eukaryotic Expression Systems Market Size by Type
8.3 Middle East & Africa Eukaryotic Expression Systems Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 GLOBAL EUKARYOTIC EXPRESSION SYSTEMS MARKET FORECAST

10.1 Global Eukaryotic Expression Systems Market Size Forecast (2018-2023)
10.2 Global Eukaryotic Expression Systems Forecast by Regions
  10.2.1 Global Eukaryotic Expression Systems Forecast by Regions (2018-2023)
  10.2.2 Americas Market Forecast
  10.2.3 APAC Market Forecast
  10.2.4 Europe Market Forecast
  10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
  10.3.1 United States Market Forecast
  10.3.2 Canada Market Forecast
  10.3.3 Mexico Market Forecast
  10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
  10.4.1 China Market Forecast
  10.4.2 Japan Market Forecast
  10.4.3 Korea Market Forecast
  10.4.4 Southeast Asia Market Forecast
  10.4.5 India Market Forecast
  10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
  10.5.1 Germany Market Forecast
  10.5.2 France Market Forecast
  10.5.3 UK Market Forecast
  10.5.4 Italy Market Forecast
  10.5.5 Russia Market Forecast
  10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
  10.6.1 Egypt Market Forecast
  10.6.2 South Africa Market Forecast
  10.6.3 Israel Market Forecast
  10.6.4 Turkey Market Forecast
  10.6.5 GCC Countries Market Forecast
10.7 Global Eukaryotic Expression Systems Forecast by Type
10.8 Global Eukaryotic Expression Systems Forecast by Application

11 KEY PLAYERS ANALYSIS

11.1 Thermo Fisher
  11.1.1 Company Details
  11.1.2 Eukaryotic Expression Systems Product Offered
  11.1.3 Thermo Fisher Eukaryotic Expression Systems Revenue, Gross Margin and Market Share (2016-2018)
  11.1.4 Main Business Overview
  11.1.5 Thermo Fisher News
11.2 Sigma Aldrich
  11.2.1 Company Details
  11.2.2 Eukaryotic Expression Systems Product Offered
  11.2.3 Sigma Aldrich Eukaryotic Expression Systems Revenue, Gross Margin and Market Share (2016-2018)
  11.2.4 Main Business Overview
  11.2.5 Sigma Aldrich News
11.3 Jena Bioscience
  11.3.1 Company Details
  11.3.2 Eukaryotic Expression Systems Product Offered
  11.3.3 Jena Bioscience Eukaryotic Expression Systems Revenue, Gross Margin and Market Share (2016-2018)
  11.3.4 Main Business Overview
  11.3.5 Jena Bioscience News
11.4 New England Biolabs
  11.4.1 Company Details
  11.4.2 Eukaryotic Expression Systems Product Offered
  11.4.3 New England Biolabs Eukaryotic Expression Systems Revenue, Gross Margin and Market Share (2016-2018)
  11.4.4 Main Business Overview
  11.4.5 New England Biolabs News
11.5 Takara Bio
  11.5.1 Company Details
  11.5.2 Eukaryotic Expression Systems Product Offered
  11.5.3 Takara Bio Eukaryotic Expression Systems Revenue, Gross Margin and Market Share (2016-2018)
  11.5.4 Main Business Overview
  11.5.5 Takara Bio News
11.6 Bio Rad
  11.6.1 Company Details
  11.6.2 Eukaryotic Expression Systems Product Offered
  11.6.3 Bio Rad Eukaryotic Expression Systems Revenue, Gross Margin and Market Share (2016-2018)
  11.6.4 Main Business Overview
  11.6.5 Bio Rad News
11.7 Promega
  11.7.1 Company Details
  11.7.2 Eukaryotic Expression Systems Product Offered
  11.7.3 Promega Eukaryotic Expression Systems Revenue, Gross Margin and Market Share (2016-2018)
  11.7.4 Main Business Overview
  11.7.5 Promega News
11.8 Agilent
  11.8.1 Company Details
  11.8.2 Eukaryotic Expression Systems Product Offered
  11.8.3 Agilent Eukaryotic Expression Systems Revenue, Gross Margin and Market Share (2016-2018)
  11.8.4 Main Business Overview
  11.8.5 Agilent News
11.9 Merck Millipore
  11.9.1 Company Details
  11.9.2 Eukaryotic Expression Systems Product Offered
  11.9.3 Merck Millipore Eukaryotic Expression Systems Revenue, Gross Margin and Market Share (2016-2018)
  11.9.4 Main Business Overview
  11.9.5 Merck Millipore News

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Table Product Specifications of Eukaryotic Expression Systems
Figure Eukaryotic Expression Systems Report Years Considered
Figure Market Research Methodology
Figure Global Eukaryotic Expression S